Ovarian aging is one of the most striking examples of biological decline in the human body. Unlike most organs, which renew themselves over decades, the ovary carries a fixed, non-renewable pool of follicles, each of which houses an immature oocyte. From mid-life onward this pool dwindles both through ovulation and through atresia, the process by which follicles degenerate. The endocrine consequences are profound: declining anti-Müllerian hormone and estrogen levels, rising follicle-stimulating hormone, irregular cycles, reduced fertility and, eventually, menopause, which itself raises the risk of osteoporosis, cardiovascular disease and neurodegeneration. While oxidative stress, DNA damage accumulation, telomere attrition and chronic low-grade inflammation have all been implicated in this process, the physical environment in which ovarian follicles live has received far less attention.

The research team began with a deceptively simple question: does the mechanical character of the ovarian stroma—the dense meshwork of collagen, fibronectin and other matrix proteins that surrounds follicles—change as the ovary ages, and if so, does that change matter? Using atomic force microscopy to probe living tissue at the nanoscale, the researchers measured the stiffness of ovarian tissue across the reproductive lifespan in mouse models and in human samples. They found a consistent and dramatic trend: aged ovaries were significantly stiffer than young ones, with matrix stiffening beginning well before overt signs of follicle depletion. Histological and second-harmonic-generation imaging revealed that this stiffening was accompanied by excessive deposition and abnormal cross-linking of collagen fibers, producing a denser, more rigid scaffold around the follicles that had once been cradled in a soft, compliant microenvironment.

Mechanobiology offers a rationale for why this matters. Cells continuously sense the elasticity of their surroundings through integrin receptors and the cytoskeleton, and matrix stiffness feeds back into gene expression, proliferation, differentiation and survival. Stiff environments have been shown to drive fibrosis and dysfunction in organs ranging from liver to heart to brain. In the ovary, follicles depend on exquisitely coordinated communication between the oocyte, the surrounding granulosa cells and the stromal theca; the investigators reasoned that a rigidifying stroma could distort these interactions, impairing follicle activation, maturation and survival. Indeed, when young ovarian follicles were cultured on artificially stiffened substrates, they showed reduced growth, compromised granulosa cell function and elevated markers of cellular stress, while follicles maintained on soft matrices retained their vigor. Conversely, softening the environment of aged follicles partially restored their developmental competence.

Having established that stiffness itself is functionally consequential, the team searched for the molecular mechanism that drives it. Transcriptomic and proteomic profiling of young and aged ovarian stroma pointed unambiguously to interleukin-11, a pro-inflammatory cytokine of the IL-6 family that signals through the IL-11 receptor and the downstream JAK-STAT3 pathway. IL-11 is best known as a fibrotic mediator: in lung, liver and kidney fibrosis models it acts as a central switch that instructs fibroblasts to proliferate, deposit extracellular matrix and activate contractile programs. The new work shows that IL-11 levels rise in the aging ovary in parallel with matrix stiffening, that stromal fibroblasts respond to IL-11 by upregulating collagen synthesis and maturation enzymes that cross-link and stiffen the matrix, and that this response is mediated by canonical STAT3-dependent transcriptional changes. In effect, IL-11 converts the ovarian stroma into a scar-like, rigid environment as the organism ages.

The causal experiments were the most striking part of the study. When the researchers administered a neutralizing antibody against IL-11 to aging female mice, or deleted the IL-11 signaling axis genetically, ovarian stiffness declined, collagen architecture normalized, and follicle numbers were preserved at levels far exceeding those of untreated age-matched controls. Treated animals retained larger pools of primordial and growing follicles, showed improved ovarian hormonal output with healthier estrous cyclicity, and produced more oocytes in response to superovulation, several of which developed into healthy embryos after fertilization. Perhaps most compelling, the treatment window was not restricted to early life: initiating IL-11 blockade in mid-aged females, after substantial follicle loss had already occurred, still measurably slowed the trajectory of ovarian decline, suggesting a realistic therapeutic horizon rather than an intervention that must begin before reproductive maturity.

The study also dissected the cellular choreography underlying the effect. Using single-cell RNA sequencing and fate-mapping approaches, the authors tracked how stromal fibroblasts transition with age into an activated, matrix-producing state reminiscent of the myofibroblasts seen in organ fibrosis. IL-11 signaling emerged as a master regulator of this transition: in its presence, fibroblasts accumulated, secreted abundant collagen and lysyl-oxidase-family cross-linking enzymes, and physically remodeled the follicular niche; in its absence, the fibroblast population remained quiescent and the matrix retained its youthful architecture. Granulosa cells, in turn, responded to the softer niche with improved proliferation, lower senescence markers and better support of oocyte meiotic quality, closing the loop between stromal mechanics and gamete health.

Experts in reproductive biology, who were not involved in the work, describe it as a conceptual advance because it relocates ovarian aging partly outside the follicle itself. Much of the field has focused on intrinsic oocyte damage or on the exhaustion of the follicle pool as a simple counting problem. The new findings imply that the niche is an active participant that can accelerate or slow that depletion, and that its mechanical state is a modifiable variable. This reframing echoes recent discoveries in other aging tissues, where extracellular matrix stiffening has emerged as a common, and pharmacologically actionable, feature of late-life decline. It also aligns with clinical observations: women with endometriosis, pelvic inflammatory disease or ovarian surgery, conditions associated with fibrosis and adhesions, often experience earlier declines in ovarian reserve, a correlation that the mechanistic model now helps to explain.

Translating these results to humans will require careful work. IL-11-blocking antibodies have already been developed and tested in early-phase clinical trials, primarily for fibrotic diseases such as pulmonary fibrosis, with a tolerability profile that the authors cite as encouraging for reproductive applications. Nevertheless, cytokines of this class serve important functions in immunity, platelet biology and tissue repair, and any fertility-oriented intervention would need to demonstrate safety for both the woman and the developing oocyte across potentially months or years of treatment. Questions also remain about timing and dosing, about whether IL-11 levels in blood or follicular fluid could serve as biomarkers to identify women most likely to benefit, and about how much of human ovarian aging is driven by matrix mechanics versus other converging insults such as mitochondrial dysfunction and genomic damage. Mouse ovaries, with their much larger follicle pools and shorter reproductive spans, are imperfect proxies for human reproductive physiology.

Even so, the implications are broad. An estimated one in six people worldwide now experiences infertility, and the age of first childbirth continues to rise across high-income countries, making the preservation of ovarian function a major public health concern. Beyond fertility, delaying ovarian senescence would postpone the hormonal transition of menopause and could reduce the cascade of age-associated conditions linked to estrogen loss. The authors suggest that IL-11 pathway modulation could eventually complement existing strategies—such as oocyte cryopreservation and in vitro maturation—by protecting the ovary itself, and possibly by improving the quality of the ovarian microenvironment into which follicles are retrieved or transplanted. More generally, the study adds the ovary to the growing list of organs in which mechanotransduction, the conversion of physical cues into biochemical signals, shapes the aging process. As the authors conclude, targeting IL-11-dependent matrix stiffness offers a proof of concept that the biophysical milieu of an aging tissue is not merely a consequence of time’s passage but a cause of it—and, crucially, one that can be modified. Whether a simple anti-fibrotic injection will one day extend the reproductive window remains to be proven in the clinic, but the ovaries of antibody-treated mice growing old in a softer, younger world provide the most persuasive evidence yet that this is a serious scientific proposition rather than wishful thinking.

The ovarian reserve is established before birth and consists primarily of primordial follicles, each containing an immature oocyte surrounded by a small layer of support cells. Most of these follicles remain dormant for years, while a small proportion is recruited into a growth process that can eventually lead to ovulation. The reserve is therefore not merely a numerical inventory of eggs. It is a living, spatially organized population embedded within a changing tissue environment. As follicles are activated, degenerate or respond to hormonal signals, the structure of the ovary itself may influence which oocytes survive and which are lost. Capturing those relationships has been difficult because conventional histology reduces a three-dimensional organ to a series of two-dimensional slices.

The approach described by the researchers addresses that problem by reconstructing the intact ovary in three dimensions. Instead of assessing isolated sections and estimating how many follicles may exist between them, whole-organ mapping allows follicles and other anatomical features to be viewed in their original spatial context. This distinction matters technically: a follicle may appear close to another structure in one section while being separated from it in three dimensions, and the apparent density of follicles can change substantially depending on the plane of observation. Three-dimensional analysis can also reveal regional differences, clustering patterns and changes in follicle distribution that traditional sampling may overlook.

That broader view is especially important for studying aging. The ovarian reserve does not decline at a perfectly uniform rate, and ovarian aging involves more than the gradual disappearance of follicles. Follicles may be lost through a process known as atresia, in which they degenerate before ovulation. The surviving follicles may also experience changes in their surrounding cells, extracellular matrix and vascular environment. Over time, the tissue may become less capable of maintaining the conditions required for follicle dormancy, growth and oocyte quality. By mapping the reserve across intact ovaries, the study makes it possible to examine aging as a coordinated transformation of an organ rather than as a single downward curve in follicle number.

The technical significance of the work lies in connecting cellular measurements with organ-scale biology. A two-dimensional section can identify a follicle and provide information about its size, structure or developmental stage. A three-dimensional map can add information about location, neighborhood and distribution. Researchers can ask whether follicles are randomly dispersed, concentrated in particular regions or reorganized as the ovary ages. They can also compare the relative positions of follicles at different developmental stages and investigate whether aging alters the physical landscape through which follicles progress. These questions are difficult to answer with conventional microscopy alone, but they are essential for understanding how local tissue conditions shape reproductive potential.

The study’s focus on intact ovaries also has implications for the way ovarian reserve is measured in clinical practice. Current assessments often rely on indirect indicators, including circulating anti-Müllerian hormone levels, antral follicle counts observed by ultrasound and a patient’s age. These measures are useful, but each captures only part of the biology. They do not directly visualize the entire population of primordial follicles, nor do they fully describe the tissue environment in which those follicles exist. A three-dimensional atlas cannot immediately replace clinical testing, but it may reveal why commonly used markers sometimes fail to predict reproductive outcomes precisely. It may also help researchers identify structural or molecular features that could eventually improve individualized fertility assessment.

The findings are likely to resonate far beyond reproductive biology because ovarian aging is connected to broader questions about healthspan. The ovary is an endocrine organ, and changes in its function can influence hormonal signaling throughout the body. The depletion of the follicular reserve and the transition toward menopause are associated with major physiological changes, although the relationships among ovarian structure, hormones and long-term health remain complex. A detailed map of how the ovary ages could provide a foundation for studying those connections. It may also help explain why the timing of reproductive aging differs among individuals and why some ovaries appear to preserve functional characteristics longer than others.

At the same time, the work should not be interpreted as evidence that aging ovaries can currently be restored or that a three-dimensional map can predict an individual woman’s fertility. Ovarian reserve is only one component of reproductive success, and the number of remaining follicles does not necessarily indicate the genetic or developmental quality of their oocytes. Human reproductive aging is influenced by genetics, endocrine regulation, environmental exposures, disease, medical treatment and chance. The value of the research is more fundamental: it creates a framework for observing how these factors may act on an organ whose internal organization has historically been difficult to study in its entirety.

The study arrives as fertility science increasingly moves toward high-resolution, data-rich models of human biology. Combining three-dimensional imaging with molecular profiling, computational analysis and longitudinal clinical data could eventually transform the ovarian reserve from an abstract estimate into a dynamic biological system that can be measured in far greater detail. For now, the work by D’Angelo and colleagues delivers a powerful conceptual shift. The ovarian reserve is not simply a diminishing number of follicles counted under a microscope; it is a spatially structured population embedded in living tissue, and its aging may depend on how that organization changes over time. By making the intact ovary visible as a three-dimensional landscape, the researchers have opened a new route toward understanding one of biology’s most consequential and least predictable aging processes.

Subject of Research: Three-dimensional organization and age-related dynamics of the ovarian reserve.

Article Title: Three-dimensional mapping of intact ovaries reveals the aging dynamics of the ovarian reserve.

Article References: D’Angelo, A., Franco-Barranco, D., Musy, M. et al. “Three-dimensional mapping of intact ovaries reveals the aging dynamics of the ovarian reserve.” Nature Aging 6, 1580–1591 (2026). https://doi.org/10.1038/s43587-026-01178-z

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s43587-026-01178-z

Keywords: ovarian reserve, ovarian aging, fertility, reproductive biology, three-dimensional imaging, follicles, oocytes, menopause, tissue mapping, aging research

“The same percentage of oocytes are being activated regardless of how old the mouse is,” says Elvan Böke, group leader at the Centre for Genomic Regulation in Barcelona and senior author of the study. “That means the ovary has a sensing mechanism which knows how many oocytes are in there and only awakens a fixed proportion.” The mechanism responsible has not yet been identified, but the researchers propose that it could involve an ovarian hormone, signals from the nervous system, or communication between follicles and surrounding tissue. Whatever the signal, the result is a system that appears to scale its activity according to the size of the reserve. This challenges the traditional image of the ovary as a passive storage site containing a fixed number of eggs that are gradually lost over time.

The discovery was made possible by combining tissue-clearing chemistry, high-resolution microscopy and artificial intelligence. The researchers transformed intact mouse ovaries into optically transparent specimens, allowing light to pass through the entire organ and making it possible to image individual follicles in three dimensions. Instead of examining thin tissue slices, which can provide only partial views and may miss the spatial relationships between cells, the team reconstructed whole ovaries digitally. AI-based image-segmentation tools then identified, counted and classified every visible oocyte according to its size and developmental state. Across more than 100 ovaries representing the full reproductive lifespan of mice, the researchers tracked over 85,000 cells, creating a dataset that captures ovarian aging at an unprecedented scale.

The resulting images show the ovary as a densely organized landscape rather than a uniform reservoir. Each ovary contains thousands of oocytes, ranging from tiny dormant cells to larger eggs enclosed within follicles that have already entered the growth phase. The researchers could follow how the distribution of these cells changed with age and compare the reproductive organs of animals that were genetically identical and raised under the same conditions. This approach revealed that ovarian aging is not simply a matter of every mouse losing eggs at the same predictable rate. By puberty, some mice possessed as many as three times more oocytes than other genetically identical animals living in the same environment.

“That is huge variability, and it is not genetic,” says Böke. The differences were already detectable before puberty, indicating that the foundations of ovarian reserve may be established very early in life, potentially during embryonic development. Mice with smaller reserves also tended to have smaller ovaries and fewer growing oocytes, suggesting that early developmental events may influence ovarian architecture and reproductive function for the rest of an animal’s life. The findings raise the possibility that an individual’s reproductive lifespan is shaped not only by genes, age or later environmental exposures, but also by biological variation arising before birth. In humans, where ovarian reserve varies considerably between individuals, the same principle could be important, although much larger studies will be needed to determine whether the pattern exists.

The three-dimensional analysis also overturned a long-standing assumption about how dormant follicles influence one another. Because dormant oocytes are packed closely together, researchers have proposed that they might suppress neighboring cells, preventing too many eggs from activating at once. The new data indicate the opposite. Regions containing the highest densities of dormant oocytes were also the regions where the greatest numbers of eggs emerged from dormancy. “This idea has always floated around, but this is the first time there’s actual data,” says Arturo D’Angelo, first author of the study. The observation suggests that local crowding does not inhibit activation and may even be associated with signals that promote it. The ovary’s internal organization could therefore be part of the mechanism that coordinates follicle recruitment.

The researchers identified another previously unrecognized bottleneck during follicle development. Many oocytes appeared to pause when they reached approximately 60 micrometres in diameter, before becoming fully responsive to hormonal signals that drive later stages of growth. This checkpoint may represent a critical decision point at which follicles either continue developing or are lost. Understanding the molecular controls operating at this stage could help explain why large numbers of oocytes disappear without ever being ovulated. It may also provide a target for future research into treatments designed to preserve ovarian function, extend reproductive lifespan or delay the hormonal changes associated with menopause. The scientists emphasize, however, that manipulating this system safely would require a detailed understanding of the signals controlling activation, growth and follicle survival.

The implications are particularly significant because female mammals are born with the oocytes they will use throughout life. Humans are estimated to begin life with approximately one million oocytes, a number that falls to around 400,000 by puberty and declines to roughly 1,000 by menopause. Only about 400 are typically ovulated during a woman’s reproductive years. Mice begin with a much smaller reserve of approximately 5,000 oocytes, but their reproductive timetable is very different: they can ovulate from both ovaries every four to five days, while women generally release one egg during a cycle of about 28 days. These differences mean that the mouse findings cannot be transferred directly to humans. Still, a system that maintains a stable fraction of eggs in an activation-ready state could represent a conserved feature of mammalian reproductive biology.

The researchers have begun testing whether their approach can be applied to human tissue. As a proof of concept, they used the method on samples of human ovarian cortex, the outer region where many dormant follicles are located. The technical workflow is now available through BiaPy, an open-source platform for AI-based image analysis, and the team has released the microscopy images and trained AI model so that other laboratories can examine the data or apply the tools to their own samples. Ignacio Arganda-Carreras, leader of the Computer Vision and Pattern Discovery group at the University of the Basque Country and a co-developer of BiaPy, says the goal was to make the method useful beyond a single study. A lifespan-scale analysis in humans would be far more difficult because ovarian tissue cannot be repeatedly collected from the same individuals over decades, but larger collections of samples from different ages could eventually reveal whether the same activation pattern exists in women.

For now, the study presents a new model of ovarian aging: one in which the organ continuously regulates its reserve, preserves a stable fraction of follicles in transition and contains developmental checkpoints that determine which eggs continue toward ovulation. The researchers caution that the work does not yet offer a treatment for infertility or menopause, and the human relevance remains to be established. It does, however, provide a detailed map of the cellular processes that govern reproductive decline. By making every oocyte visible in its three-dimensional context, the study turns ovarian aging from a largely statistical process into something that can be observed cell by cell. The authors hope that this new perspective will lead to investigations into the signals that measure ovarian reserve, explain why individuals begin adulthood with different numbers of eggs and reveal why so many oocytes are lost without ever contributing to reproduction.

Subject of Research: Animals

Article Title: Three-dimensional mapping of intact ovaries reveals the aging dynamics of the ovarian reserve

News Publication Date: 12-Aug-2026

Web References: https://doi.org/10.1038/s43587-026-01178-z

References: Nature Aging, DOI: 10.1038/s43587-026-01178-z

Image Credits: Arturo D’Angelo/Centre for Genomic Regulation

Keywords: ovarian aging, ovarian reserve, oocytes, follicles, reproductive biology, fertility, menopause, three-dimensional imaging, tissue clearing, artificial intelligence, reproductive lifespan, infertility